{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T21:41:12Z","timestamp":1773351672757,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.jss.2011.02.039","type":"journal-article","created":{"date-parts":[[2011,3,28]],"date-time":"2011-03-28T18:33:17Z","timestamp":1301337197000},"page":"e101-e107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Azelnidipine, a New Calcium Channel Blocker, Promotes Skin Wound Healing in Diabetic Rats"],"prefix":"10.1016","volume":"169","author":[{"given":"Mansooreh","family":"Bagheri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behnam Moein","family":"Jahromi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Mirkhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhabiz","family":"Solhjou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Noorafshan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Amirghofran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2011.02.039_bib1","unstructured":"National Diabetes Information Clearinghouse. National Diabetes Statistics 2007. Available at: http:\/\/diabetes.niddk.nih.gov\/dm\/pubs\/statistics\/index.htm. Accessed March 2011."},{"key":"10.1016\/j.jss.2011.02.039_bib2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2337\/diabetes.54.3.855","article-title":"Topical pretreatment of diabetic rats with all-trans retinoic acid improves healing of subsequently induced abrasion","volume":"54","author":"Lateef","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jss.2011.02.039_bib3","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1152\/ajpendo.00150.2009","article-title":"Endothelium-specific GTP cyclohydrolase I overexpression accelerates refractory wound healing by suppressing oxidative stress in diabetes","volume":"296","author":"Tie","year":"2009","journal-title":"Am J Physiol Edocrinol Metab"},{"key":"10.1016\/j.jss.2011.02.039_bib4","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(03)13169-8","article-title":"Diabetic foot ulcers","volume":"361","author":"Jeffcoate","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jss.2011.02.039_bib5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jss.2011.02.039_bib6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0039-6060(97)90105-7","article-title":"Diabetes-impaired healing and reduced wound nitric oxide synthesis: A possible pathophysiologic correlation","volume":"121","author":"Schaffer","year":"1997","journal-title":"Surgery"},{"key":"10.1016\/j.jss.2011.02.039_bib7","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1523-1755.2002.00237.x","article-title":"Nitric oxide drives skin repair: Novel function of an established mediator","volume":"61","author":"Frank","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.jss.2011.02.039_bib8","first-page":"406","article-title":"Role of nitric oxide in wound repair","volume":"183","author":"Witte","year":"2002","journal-title":"Am J\u00a0Surg"},{"key":"10.1016\/j.jss.2011.02.039_bib9","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1172\/JCI117557","article-title":"Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P","volume":"94","author":"Ziche","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jss.2011.02.039_bib10","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1172\/JCI119868","article-title":"Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells","volume":"100","author":"Papapetropoulos","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jss.2011.02.039_bib11","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1096\/fasebj.13.14.2002","article-title":"Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair","volume":"13","author":"Frank","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.jss.2011.02.039_bib12","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.4049\/jimmunol.158.5.2375","article-title":"Nitric oxide, an autocrine regulator of wound fibroblast synthetic function","volume":"158","author":"Schaffer","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jss.2011.02.039_bib13","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1152\/ajpcell.1996.270.3.C794","article-title":"Nitric oxide is necessary for a switch from stationary to locomoting phenotype in epithelial cells","volume":"170","author":"Noiri","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jss.2011.02.039_bib14","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2337\/diabetes.51.2.522","article-title":"Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes","volume":"51","author":"Kim","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.jss.2011.02.039_bib15","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1161\/01.CIR.0000051367.92927.07","article-title":"High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: Role of protein kinase C and reactive oxygen species","volume":"107","author":"Cosentino","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jss.2011.02.039_bib16","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1161\/01.CIR.0000012748.58444.08","article-title":"Mechanisms of increased vascular superoxide production in human diabetes mellitus: Role of NAD(P)H oxidase and endothelial nitric oxide synthase","volume":"105","author":"Guzik","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jss.2011.02.039_bib17","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.2165\/00003495-200363230-00004","article-title":"Azelnidipine","volume":"63","author":"Wellington","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.jss.2011.02.039_bib18","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.fjc.0000205497.90765.b0","article-title":"Comparative effect of azelnidipine and other Ca-channel blockers on the induction of inducible nitric oxide synthase in vascular smooth muscle cells","volume":"47","author":"Ma","year":"2006","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jss.2011.02.039_bib19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/147323000403200210","article-title":"Antioxidant effect of a new calcium antagonist, azelnidipine, in cultured human arterial endothelial cells","volume":"32","author":"Shinomiya","year":"2004","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jss.2011.02.039_bib20","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/00005344-200405000-00016","article-title":"Azelnidipine, a newly developed long acting calcium antagonist, inhibits tumor necrosis factor alpha-induced interleukin-8 expression in endothelial cells through its anti-oxidant properties","volume":"43","author":"Yamagishi","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jss.2011.02.039_bib21","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/01.hjh.0000173521.91104.5f","article-title":"Effect of combination of calcium antagonist, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice","volume":"23","author":"Suzuki","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.jss.2011.02.039_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/10641960601096745","article-title":"Long-acting calcium channel blocker, azelnidipine, increases endothelial nitric oxide synthase in the brain and inhibits sympathetic nerve activity","volume":"29","author":"Kimura","year":"2007","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.jss.2011.02.039_bib23","unstructured":"World Medical Association Statement on Animal Use in Biomedical Research. Available at: http:\/\/www.wma.net. Revised in October 2008. Accessed March 2011."},{"key":"10.1016\/j.jss.2011.02.039_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.carpath.2008.10.015","article-title":"A review of state-of-the-art stereology for better quantitative 3D morphology in cardiac research","volume":"19","author":"M\u00fchlfeld","year":"2010","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jss.2011.02.039_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.biomaterials.2006.08.037","article-title":"Stereolocical method to assess tissue response for tissue engineered scaffolds","volume":"28","author":"Garcia","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jss.2011.02.039_bib26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/s30800276","article-title":"Measurement of nitric oxide production in biological systems by using griess reaction assay","volume":"3","author":"Sun","year":"2003","journal-title":"Sensors"},{"key":"10.1016\/j.jss.2011.02.039_bib27","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1161\/01.CIR.0000137969.87365.05","article-title":"Gene therapy of endothelial nitric oxide synthase and manganese superoxide dismutase restores delayed wound healing in type 1 diabetic mice","volume":"110","author":"Luo","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jss.2011.02.039_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2009.03.053","article-title":"Propranolol improves cutaneous wound healing in streptozotocin-induced diabetic rats","volume":"611","author":"Romana-Souza","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jss.2011.02.039_bib29","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1053\/meta.2002.35185","article-title":"L-Arginine supplementation enhances diabetic wound healing: Involvement of the nitric oxide synthase and arginase pathways","volume":"51","author":"Witte","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.jss.2011.02.039_bib30","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jss.2009.01.024","article-title":"Effect of pravastatin on experimental diabetic wound healing","volume":"161","author":"Laing","year":"2010","journal-title":"J Surg Res"},{"key":"10.1016\/j.jss.2011.02.039_bib31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/01.RES.88.2.e14","article-title":"Mechanisms underlying endothelial dysfunction in diabetes mellitus","volume":"88","author":"Hink","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.jss.2011.02.039_bib32","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1124\/jpet.106.108894","article-title":"Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan","volume":"319","author":"Iwai","year":"2006","journal-title":"JPET"},{"key":"10.1016\/j.jss.2011.02.039_bib33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/01.HYP.0000113627.08110.6f","article-title":"Calcium channel blocker azelnidipine enhances vascular protective effects of at1 receptor blocker olmesartan","volume":"43","author":"Jinno","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.jss.2011.02.039_bib34","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1507\/endocrj.K07-063","article-title":"Calcium channel blocker, azelnidipine, reduces lipid hyperoxides in patient with type 2 diabetes independent of blood pressure","volume":"54","author":"Ohmura","year":"2007","journal-title":"Endocrine J"},{"key":"10.1016\/j.jss.2011.02.039_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clindermatol.2006.09.007","article-title":"Pathophysiology of acute wound healing","volume":"25","author":"Li","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jss.2011.02.039_bib36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00000658-199108000-00012","article-title":"The local effects of cachectin\/tumor necrosis factor on wound healing","volume":"214","author":"Salomon","year":"1991","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2011.02.039_bib37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000129163","article-title":"Tumor necrosis factor alpha inhibits wound healing in the rat","volume":"23","author":"Rapala","year":"1991","journal-title":"Eur Surg Res"},{"key":"10.1016\/j.jss.2011.02.039_bib38","first-page":"671","article-title":"Azelnidipine, a new long-acting calcium-channel blocker inhibits tumor necrosis factor-\u03b1-induced monocyte chemoattractant protein-1 expression in endothelial cells","volume":"34","author":"Matsui","year":"2006","journal-title":"JIMR"},{"key":"10.1016\/j.jss.2011.02.039_bib39","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1291\/hypres.31.1147","article-title":"Combination therapy with rennin-angiotensin system inhibitors and the calcium channel blocker azelnidipine decreases plasma inflammatory markers and urinary oxidative stress markers in patients with diabetic nephropathy","volume":"31","author":"Ogawa","year":"2008","journal-title":"Hypertens Res"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480411001569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480411001569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T14:38:16Z","timestamp":1758379096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480411001569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0022480411001569"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2011.02.039","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azelnidipine, a New Calcium Channel Blocker, Promotes Skin Wound Healing in Diabetic Rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2011.02.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}